SOAT1 and neoplasm: Research exploring the role of this pathway in anti-tumor immunity has uncovered a diverse array of downstream targets—including oncogenes, microRNAs, and various co-regulators—that influence specific cellular phenotypes in response to JAK-STAT activation.